These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 6718635)

  • 21. Blockade by apomorphine of haloperidol-induced dyskinesia in schizophrenic patients.
    Gessa R; Tagliamonte A; Gessa GL
    Lancet; 1972 Nov; 2(7784):981-2. PubMed ID: 4116875
    [No Abstract]   [Full Text] [Related]  

  • 22. [Use and value of the therapeutic neuroleptic-bromocriptine combination in schizophrenia].
    Lombertie ER; Durelle G; Fuseau A
    Ann Med Psychol (Paris); 1995 Oct; 153(8):531-4. PubMed ID: 8561400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Update on apomorphine for the rapid treatment of hypomobility ("off") episodes in Parkinson's disease.
    Obering CD; Chen JJ; Swope DM
    Pharmacotherapy; 2006 Jun; 26(6):840-52. PubMed ID: 16716137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Various aspects of the interaction between the dopamine and opiate systems in schizophrenia].
    Anokhina IP
    Vestn Akad Med Nauk SSSR; 1982; (1):37-40. PubMed ID: 7064531
    [No Abstract]   [Full Text] [Related]  

  • 25. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study.
    Bai YM; Yu SC; Lin CC
    J Clin Psychiatry; 2003 Nov; 64(11):1342-8. PubMed ID: 14658949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clozapine in tardive Tourette syndrome.
    Jaffe E; Trémeau F; Sharif Z; Reider R
    Biol Psychiatry; 1995 Aug; 38(3):196-7. PubMed ID: 7578666
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of gradual decrease and discontinuation of neuroleptics on clinical condition and tardive dyskinesia [proceedings].
    Branchey MH; Branehey LB; Richardson MA
    Psychopharmacol Bull; 1981 Jan; 17(1):118-20. PubMed ID: 7232639
    [No Abstract]   [Full Text] [Related]  

  • 28. Psychopathological and cognitive correlates of tardive dyskinesia in schizophrenia and other disorders treated with neuroleptic drugs.
    Waddington JL
    Adv Neurol; 1995; 65():211-29. PubMed ID: 7872142
    [No Abstract]   [Full Text] [Related]  

  • 29. [Tardive dyskinesia: pergolid, a possible therapeutic option].
    Diehl A; Braus DF; Büchel C; Krumm B; Medori R; Gattaz WF
    Psychiatr Prax; 2003 Sep; 30(6):333-7. PubMed ID: 12970819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improvement of tardive dyskinesia with risperidone: a case report.
    Kooptiwoot S; Settachan T
    J Med Assoc Thai; 2000 Nov; 83(11):1430-2. PubMed ID: 11215878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolactin response in tardive dyskinesia.
    Wolf ME; Bowie L; Keener S; Mosnaim AD
    Biol Psychiatry; 1982 Apr; 17(4):485-90. PubMed ID: 7082714
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of tardive dyskinesia by single and repeated application of 7-methoxytacrin.
    Hanus H; Tůtma I; Zapletálek M; Fusek J; Hrdina V
    Homeost Health Dis; 1991; 33(5-6):301-4. PubMed ID: 18265509
    [No Abstract]   [Full Text] [Related]  

  • 33. Clozapine treatment of psychosis in patients with tardive dystonia: report of three cases.
    Friedman JH
    Mov Disord; 1994 May; 9(3):321-4. PubMed ID: 7913739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Tardive dyskinesia: etiology, clinical features and therapy].
    Furer V; Lichtenberg P; Heresco-Levy U
    Harefuah; 2001 Mar; 140(3):248-52. PubMed ID: 11303354
    [No Abstract]   [Full Text] [Related]  

  • 35. An open-label trial of discontinuing benzodiazepines in patients with chronic schizophrenia.
    Nakajima S; Uchida H; Suzuki T; Tomita M; Tsunoda K; Kitta M; Takeuchi H; Nomura K; Watanabe K; Kashima H
    J Clin Psychopharmacol; 2007 Aug; 27(4):401-3. PubMed ID: 17632230
    [No Abstract]   [Full Text] [Related]  

  • 36. [Study on dopamine metabolite in cerebrospinal fluid of schizophrenics and epilepsics].
    Jiang S; Chen X; Liao W
    Hunan Yi Ke Da Xue Xue Bao; 1998; 23(2):155-6. PubMed ID: 10681831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pisa syndrome-like peculiar posture occurred while running was successfully improved with risperidone.
    Harada K; Saito T
    Psychiatry Clin Neurosci; 2006 Dec; 60(6):771-2. PubMed ID: 17109715
    [No Abstract]   [Full Text] [Related]  

  • 38. Degree of selectivity of pergolide as an agonist at presynaptic versus postsynaptic dopamine receptors: implications for prevention or treatment of tardive dyskinesia.
    Fuller RW; Clemens JA; Hynes MD
    J Clin Psychopharmacol; 1982 Dec; 2(6):371-5. PubMed ID: 7174859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can elderly nursing home patients with involuntary grimacing and vocalization be helped with psychopharmacological agents?
    Shader RI
    J Clin Psychopharmacol; 1984 Apr; 4(2):121. PubMed ID: 6584453
    [No Abstract]   [Full Text] [Related]  

  • 40. Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: a prospective study using single-dose challenges.
    Katzenschlager R; Hughes A; Evans A; Manson AJ; Hoffman M; Swinn L; Watt H; Bhatia K; Quinn N; Lees AJ
    Mov Disord; 2005 Feb; 20(2):151-7. PubMed ID: 15390035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.